Vor Biopharma Inc. (VOR) Misses Q3 EPS by 2c

Vor Biopharma Inc. (NASDAQ: VOR) reported Q3 EPS of ($0.49), $0.02 worse than the analyst estimate of ($0.47).

For earnings history and earnings-related data on Vor Biopharma Inc. (VOR) click here.

You May Also Be Interested In

• Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
• Keefe, Bruyette & Woods Starts Arrow Financial Corporation (AROW) at Market Perform
• Starwood Property Trust (STWD) Reiterated at Market Outperform by Citizens